Ledger.Open graph →
SEC Form D · filed September 21, 2017

Tilos Therapeutics, Inc

Offering
$4.0M
Sold
$3.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Roger Kitterman · Arlington, MADirectorBarbara Fox · Waltham, MAExec · DirectorJohn Edwards · American Fork, UTExec · DirectorRoger Kitterman · Waltham, MADirectorMartin Heidecker · Santa Monica, CADirectorJulius Knowles · Waltham, MADirectorBarbara Fox · Waltham, MAExec · DirectorJohn Edwards · Lexington, MAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗